柴胡疏肝散加减治疗肝郁型不寐的临床观察.docx

柴胡疏肝散加减治疗肝郁型不寐的临床观察\o分享到微博\o分享到微信\o分享到QQ\o分享到QQ空间

【摘要】目的：分析肝郁型不寐患者实施柴胡疏肝散加减治疗的价值。方法：以60例肝郁型不寐患者为样本，样本在2022年1月—2023年12月入选，按照数字法分组，即对照组和研究组，均有30例，对照组行艾司唑仑治疗，研究组在对照组基础上联合柴胡疏肝散加减治疗，比较两组睡眠质量、症状积分以及有效率。结果：治疗前，研究组和对照组睡眠质量评分无差异，P0.05；治疗后，两组睡眠质量评分均低于治疗前，且研究组睡眠质量评分低于对照组，P0.05。治疗前，研究组和对照组症状积分无差异，P0.05；治疗后，两组症状积分均下降，且研究组症状积分低于对照组，P0.05。研究组有效率达到了96.67%，明显高于对照组的76.67%，差异显著，P0.05。结论：柴胡疏肝散加减方案的有效率高，可以显著改善患者睡眠质量，推动肝郁型不寐患者的康复。

【关键词】肝郁型不寐；有效率；症状积分；柴胡疏肝散

ClinicalObservationofChaihuShuganSanmodifiedtreatmentforinsomniaofliverstagnationtype

LIJing

XinjiekouCommunityHealthServiceCenter，XichengDistrict，BeijingCity，Beijing100035，China

【Abstract】Objective：ToanalyzethevalueofimplementingmodifiedChaihuShuganSaninthetreatmentofinsomniapatientswithliverdepressiontype.Methods：Asampleof60patientswithliverdepressiontypeinsomniawereselectedfromJanuary2022toDecember2023，andtheyweredividedintotwogroupsusingthenumericalmethod，namelythecontrolgroupandthestudygroup，with30casesineachgroup.Thecontrolgroupreceivedtreatmentwithestazolam，whilethestudygroupreceivedtreatmentwithmodifiedChaihuShuganSanonthebasisofthecontrolgroup.Thesleepquality，symptomscores，andeffectiveratesofthetwogroupswerecompared.Results：Therewasnosignificantdifferenceinsleepqualityscoresbetweenthestudygroupandthecontrolgroupbeforetreatment，P0.05；Aftertreatment，thesleepqualityscoresofbothgroupswerelowerthanbeforetreatment，andthesleepqualityscoresofthestudygroupwerelowerthanthoseofthecontrolgroup，P0.05.Therewasnodifferenceinsymptomscoresbetweenthestudygroupandthecontrolgroupbeforetreatment，P0.05；Aftertreatment，thesymptomscoresofbothgroupsdecreased，andthesymptomscoresofthestudygroupwerelowerthanthoseofthecontrolgroup，P0.05.Theeffectiverateinthestudygroupreached96.67%，whichwassignificantlyhigherthan76.67%inthecontr